-
Abstract:
Although its service-oriented architecture-based platform and enterprise solutions will not likely be "all things to all
people" any time soon, Oracle might be showing its ability to further develop its own enterprise infrastructure and applications
via a blitz acquisition of a Collaxa, a small and focus (...)
Excerpt related to
drug summary:
Although its service-oriented architecture-based platform and enterprise solutions will not likely be "all things to
all people" any time soon, Or...
Published:
2005-03-14
-
Abstract:
Although its PLM solutions will not likely be the "all things to all people" any time soon, Oracle might be showing us its
ability to develop its own applications in collaborative effort with its prominent customers. (...)
Excerpt related to
drug summary:
... Event Summary. ... several industries, such as support for electronic
signatures and secure audit trails (for compliance with the Food and Drug Administration's [FDA ...
Published:
2004-01-05
-
Abstract:
We may soon find radio frequency identification (RFID) tags routinely associated with common products. However, in order
for RFID to achieve its full potential, the gap between the vision of RFID and the current realities of RFID must be closed. (...)
Excerpt related to
drug summary:
... Reduction in product diversion by tracking cross-market movement of drug shipments from
low price to high price regions. Examples. ... Summary. ...
Published:
2006-01-25
-
Abstract:
A consolidation within the warehouse management systems/ supply chain execution market, which many pundits had long been
predicting, but had hardly taken place for various reasons, finally seems to be happening. (...)
Excerpt related to
drug summary:
RedPrairie to Spread Across Europe through LIS Acquisition Part One: Event Summary. PJ Jakovljevic - April
28, 2004. Comments: 0. Read Comments Event Summary. ...
Published:
2004-04-28
-
Abstract:
For years, Catalyst International was a leading public WMS/SCE vendor before missteps by its previous management team caused
serious problems in strategy and execution. Over the past few years Catalyst's turnaround strategy has returned it to growth
and profitability. As a result, it has recently been ac (...)
Excerpt related to
drug summary:
Will Recent Acquisition Catalyze Catalyst’s Strategy? Part One: Event Summary. PJ Jakovljevic - October 25,
2004. Comments: 0. Read Comments Event Summary. ...
Published:
2004-10-25
-
Abstract:
For years, Catalyst International was a leading public WMS/SCE vendor before missteps by its previous management team caused
serious problems in strategy and execution. Over the past few years Catalyst's turnaround strategy has returned it to growth
and profitability. As a result, it has recently been ac (...)
Excerpt related to
drug summary:
Will Recent Acquisition Catalyze Catalyst’s Strategy? Part One: Event Summary. PJ Jakovljevic - October 25,
2004. Comments: 0. Read Comments Event Summary. ...
Published:
2004-10-25
-
Abstract:
This article talks about recent and expected FDA regulations and how RFID can help meet those requirements while improving
supply chain performance. (...)
Excerpt related to
drug summary:
This article talks about recent and expected FDA regulations and how RFID can help meet those requirements while improving
supply chain performance.
Published:
2004-10-20
-
Abstract:
The hype around the adoption of RFID as the 'hot new technology' continues. The reality is that RFID, despite the fact that
this is a relatively mature technology, is still far from mainstream. (...)
Excerpt related to
drug summary:
... A specific example is pharmaceutical supply chains (see Cold Chain report summary).
... by some manufacturers, large wholesalers, some large chain drug stores, and ...
Published:
2005-06-28
-
Abstract:
The hype around the adoption of RFID as the 'hot new technology' continues. The reality is that RFID, despite the fact that
this is a relatively mature technology, is still far from mainstream. (...)
Excerpt related to
drug summary:
... A specific example is pharmaceutical supply chains (see Cold Chain report summary).
... by some manufacturers, large wholesalers, some large chain drug stores, and ...
Published:
2005-06-28
-
Abstract:
Preparing Yourself for the EHR Mandate in Massachusetts.Search for Articles and Other Solutions to Characterize Your Comparison
In Relation To Preparing Yourself for the EHR Mandate in Massachusetts. In a climate of economic crisis, federal and state
governments are examining ways to evolve the health car (...)
Excerpt related to
drug summary:
Preparing Yourself for the EHR Mandate in Massachusetts.Search for Articles and Other Solutions to Characterize Your Comparison
In Relation To Prep...
Published:
2010-03-11
-
Abstract:
SAP Support of the Health Care Supply Chain's Ongoing Effort to Ensure Patient Safety and Drive Business Value. Documents
and Other Software to Use In Your Health Care System and in Relation To Supply Chain and Business Value. Electronic product
code information services (EPCIS) is a standard mechanism fo (...)
Excerpt related to
drug summary:
SAP Support of the Health Care Supply Chain's Ongoing Effort to Ensure Patient Safety and Drive Business Value. Documents
and Other Software to Use...
Published:
2010-03-11
-
Abstract:
Catalyst serves customers in several different industries, representing several major vertical market categories, and it
targets industries that have the most demanding supply chain requirements, hoping this should enable it to leverage its expertise
and experience for competitive advantage. (...)
Excerpt related to
drug summary:
... This is Part Three of a four-part note. Part One presented the event summary. ...
Part One presented the event summary. Part Two presented the current strategy. ...
Published:
2004-10-28
-
Abstract:
Catalyst serves customers in several different industries, representing several major vertical market categories, and it
targets industries that have the most demanding supply chain requirements, hoping this should enable it to leverage its expertise
and experience for competitive advantage. (...)
Excerpt related to
drug summary:
... This is Part Three of a four-part note. Part One presented the event summary. ...
Part One presented the event summary. Part Two presented the current strategy. ...
Published:
2004-10-28
-
Abstract:
Existing customers should be comforted by the backing of a financially stable parent company with money to invest. Although
this acquisition sounds like a very positive event, and ComVest and Catalyst appear to have strategic growth intentions, look
for future proof in the actions they take in the coming (...)
Excerpt related to
drug summary:
... This is Part Four of a four-part note. Part One presented the event summary. Part Two
presented the current strategy. Part Three discussed Catalyst and SAP. ...
Published:
2004-10-29
-
Abstract:
Catalyst is one of the first supply chain execution suppliers to offer both the "flow-through" functionality and traditional
warehouse management features in one system, allowing a facility to run in either or both modes. Its current strategy, termed
"Best-for-Business," is to offer componentized product (...)
Excerpt related to
drug summary:
... This is Part Two of a four-part note. Part One presented the event summary. ...
This concludes Part Two of a four-part note. Part One presented the event summary. ...
Published:
2004-10-26
-
Abstract:
Existing customers should be comforted by the backing of a financially stable parent company with money to invest. Although
this acquisition sounds like a very positive event, and ComVest and Catalyst appear to have strategic growth intentions, look
for future proof in the actions they take in the coming (...)
Excerpt related to
drug summary:
... This is Part Four of a four-part note. Part One presented the event summary. Part Two
presented the current strategy. Part Three discussed Catalyst and SAP. ...
Published:
2004-10-29
-
Abstract:
Catalyst is one of the first supply chain execution suppliers to offer both the "flow-through" functionality and traditional
warehouse management features in one system, allowing a facility to run in either or both modes. Its current strategy, termed
"Best-for-Business," is to offer componentized product (...)
Excerpt related to
drug summary:
... This is Part Two of a four-part note. Part One presented the event summary. ...
This concludes Part Two of a four-part note. Part One presented the event summary. ...
Published:
2004-10-26
-
Abstract:
ACCPAC continues to enhance the PRO series and Advantage series product lines. (...)
Excerpt related to
drug summary:
... This is Part Three of an eight-part note. Parts One and Two began the Event Summary.
Parts Four, Five, and Six will discuss the Market Impact. ...
Published:
2004-06-04
-
Abstract:
Invensys must communicate its successes and strategy to the marketplace, and must aggressively invest in customer satisfaction,
marketing, and sales. IPS must convince customers and prospects that it is here to stay; while the functionally rich products
are great advantages, many other considerations mak (...)
Excerpt related to
drug summary:
Invensys must communicate its successes and strategy to the marketplace, and must aggressively invest in customer satisfaction,
marketing, and sal...
Published:
2003-05-14
-
Abstract:
MAPICS hereby joins the raft of enterprise resource planning (ERP) vendors that are making their way into the product lifecycle
management (PLM) market by bundling or partnering strategically to embed PLM functions within their suites. (...)
Excerpt related to
drug summary:
Is MAPICS Getting the Magic of PLM? Part Three: Challenges and User Recommendations. Jim Brown and PJ Jakovljevic - July 22,
2004. Comments: 0. Read Comments ...
Published:
2004-07-22